Issue Brief

What Would Your Group Do With $75 Million?

April 18, 2012
Drug Policy Alliance

In March 2011, the Drug Policy Alliance and the Institute for Juvenile Justice Reform and Alternatives released a major report about the cost of marijuana possession arrests in NYC — at $75 million a year, the costs is quite high.

DPA and IJJRA asked groups across NYC how they would like the City to spend $75 million, instead of arresting people for marijuana possession. This fact sheet details their responses.

Marijuana Arrests in NYC

April 18, 2012
Drug Policy Alliance

Despite New York state decriminalizing marijuana possession in 1977, New York City is the marijuana arrest capital of the world. Recent changes in policing practices that take advantage of a loophole in the law led to over 50,000 marijuana possession arrests in 2010 and 2011. This issue brief examines New York's marijuana laws, the impact of policing policy and practices, and solutions that would save the state over $75 million a year.

Testimony of Tamar Todd: Hearing on Indiana Senate Bill No. 192

February 15, 2011

Testimony of Tamar Todd, Staff Attorney, Drug Policy Alliance, Office of Legal Affairs at the Hearing on Indiana Senate Bill No. 192 (To require the criminal law and sentencing policy study committee to study issues relating to marijuana.)

CA Board of Equalization Analysis of AB 390

July 15, 2009

Among other things, this bill would impose a fee of fifty dollars ($50) per ounce on the retail sale of marijuana in this state. The Board would be required to administer and collect the fee on or after a specified date, and the funds would be dedicated to drug education, awareness, and rehabilitation programs. This analysis only addresses the provisions which impact the State Board of Equalization.

Syringe Access and HIV Prevention

For more than two decades, removal of the ban on federal funding for syringe exchange programs (SEPs) was a top policy priority for amfAR. Following the removal of the ban by Congress in December 2009, amfAR is now working to encourage effective implementation of federal support for SEPs and to ensure the continued availability of federal resources for these evidence-based HIV prevention programs.

The U.S. Conference of Mayors 76th Annual Meeting

June 20, 2008

Resolutions adopted at 2008 annual meeting.

DEA Ruling on Rescheduling Marijuana

September 6, 1988
Francis L. Young, Administrative Law Judge

The principle issue here is whether the marijuana plant should lawfully be transferred from Schedule I to Schedule II of the schedules established by the Controlled Substances Act. Ruling of Drug Enforcement Administration Administrative Law Judge Francis L. Young, "In the Matter of Marijuana Rescheduling," finding that: "Marijuana, in its natural form, is one of the safest therapeutically active substances known to man. By any measure of rational analysis marijuana can be safely used within a supervised routine of medical care."

The Holder Memorandum: Memorandum for Selected United State Attorneys on Investigations and Prosecutions in States Authorizing the Medical Use of Marijuana

October 19, 2009
U.S. Department of Justice: Office of the Deputy Attorney General

This memorandum provides clarification and guidance to federal prosecutors in States that have enacted laws authorizing the medical use of marijuana. These laws vary in their substantive provisions and in the extent of state regulatory oversight, both among the enacting States and among local jurisdictions within those States. Rather than developing different guidelines for every possible variant of state and local law, this memorandum provides uniform guidance to focus federal investigations and prosecutions in these States on core federal enforcement priorities.

Marijuana Policy Project Resource Collection

Handouts, reports, briefing papers and other resources collected by the Marijuana Policy Project.

Testing for Drugs of Abuse in Children and Adolescents: Addendum—Testing in Schools and at Home

March 1, 2007
American Academy of Pediatrics

The AAP explains its opposition to involuntary drug testing of adolescents at school or at home, and encourages parents who are concerned that their child may be using drugs or alcohol to consult their child’s pediatrician rather than rely on school or home-based drug testing.

Page 2 of 3
Syndicate content